Hemo Organic Ltd Stock Price Today (NSE: HEMORGANIC)

Hemo Organic Ltd

21.16+0.00 (+0.00%)
Market Open

Fundamental Score

...

Hemo Organic Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Hemo Organic Ltd share price today is 21.16, up +0.00% on NSE/BSE as of 17 June 2026. Hemo Organic Ltd (HEMORGANIC) is a Small-cap company in the Trading & Distributors sector with a market capitalisation of 4.15 (Cr). The 52-week high for HEMORGANIC share price is 22.51 and the 52-week low is 8.08. At a P/E ratio of 34.62x, HEMORGANIC is currently trading below its industry average P/E of 35.45x.

Hemo Organic Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
21.22
Low
10.50
Volume
17.1K
Change
+67.48%

Hemo Organic Ltd share price chart: 67.48% return over the past month. 52-week high ₹22.51, 52-week low ₹8.08.

Hemo Organic Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
19.4220.3818.5019.3116.77K (Cr)
19.1220.1018.2019.429.59K (Cr)
17.3319.1517.3319.1542.09K (Cr)
19.2019.2019.2019.200.00 (Cr)
19.2019.2019.2019.200.00 (Cr)
21.2221.2219.2019.2060.00K (Cr)
20.2120.2120.2120.213.72K (Cr)
19.2519.2519.2519.2512.30K (Cr)
18.3418.3418.3418.344.88K (Cr)
17.4717.4717.4717.473.34K (Cr)

Hemo Organic Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
19.1220.3818.2019.31+0.99%
10.5121.2210.5019.15+82.21%
12.0012.529.7111.00-8.33%
16.0416.0411.7011.70-27.06%
12.9417.0312.3516.36+26.43%
16.8418.5714.0614.33-14.90%
11.9922.5111.9817.18+43.29%
8.4014.038.3611.42+35.95%
9.5411.388.128.40-11.95%
8.9911.848.319.50+5.67%
9.3510.398.088.95-4.28%
10.7411.158.558.95-16.67%

AI Research Briefing

Powered by Gemini · 2026-04-08

Hemo Organic is a momentum-driven micro-cap with poor fundamentals and a high risk of collapse.

Research Confidence
2.0/10Low
MICRO-CAP DARK HORSEBreakout in the last 1 month (42.62%) [cite: Brief], but potentially unsustainable.P/E of 34.62x [cite: Brief] is fair compared to the industry P/E of 35.45x [cite: Brief], but misleading due to low profitability.

WHAT'S HAPPENING NOW

Live search reveals no major catalysts for Hemo Organic Ltd in the last 3-4 weeks. The pre-scraped news indicates a downgrade to 'Strong Sell' by Markets Mojo on 2026-04-07.

CORE STORY

Micro-cap trading play, susceptible to volatility and operator influence. Not a long-term investment.

Why Now
  • Recent price surge of 42.62% in 1 month [cite: Brief]
  • Micro-cap speculative interest
  • 5Y Sales CAGR of 54.93% [cite: Brief]
Potential Catalysts
  • Positive news flow (unlikely)
  • Operator activity
  • Improved financials (highly unlikely)
Key Risks
  • Micro/SME cap - high liquidity risk
  • Negative OPM of -15.92% [cite: Brief]
  • Negative Free Cash Flow of ₹-1.45 Cr [cite: Brief]
Institutional Activity

Promoter holding is low at 16.85% [cite: Brief], indicating a lack of confidence.

Macro Context

Uncertainty in the trading and distribution sector.

Cash Flow Quality

Profit is not converting to cash. Free Cash Flow 5Y: ₹-1.45 Cr [cite: Brief]

3–6 Month Outlook

Expect a sharp correction in the next 3-6 months as momentum fades and fundamentals catch up. Downside risk is significant.

Primary Thesis Risk

The company's poor financials and low promoter holding make it vulnerable to a complete collapse.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Return on Equity (ROE)

N/A

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

2.65%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

-15.92%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Hemo Organic Ltd Valuation Check

Average

Price to Earnings (P/E)

34.62x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

35.45x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Good

Promoter Holding

16.85%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

62.50%

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

54.93%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

58.49%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

58.49%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Debt to Equity Ratio

N/A

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-1.45 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Hemo Organic Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of HEMORGANIC across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Robust Profit Growth (62.50%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Consistent Growth Track Record (54.93% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (58.49% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (58.49% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Suboptimal ROCE (2.65%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (-15.92%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Negative Free Cash Flow (₹-1.45 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (16.85%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Hemo Organic Ltd vs Trading & Distributors Peers

Peer Comparison - Trading & Distributors

Compare Hemo Organic Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
38.9/100
21
₹4.15
34.6
Average
2.65%
Poor
58.49%
Excellent
54.93%
Excellent
0.00%
Redington Ltd...
REDINGTON532805
58.5/100
230
₹22049.92
16.1
Average
14.39%
Average
18.90%
Good
0.3
Excellent
17.72%
Excellent
14.06%
Good
2.41%
MMTC Ltd...
MMTC513377
32.1/100
65
₹8949.04
127.3
Average
5.87%
Poor
7.70%
Poor
0.0
Excellent
19.08%
Excellent
-86.52%
Poor
0.00%
MSTC Ltd...
MSTCLTD542597
63.7/100
490
₹3458.41
15.7
Average
28.37%
Excellent
29.26%
Excellent
0.2
Excellent
15.18%
Excellent
-24.06%
Poor
8.24%
24.7/100
405
₹3333.57
49.5
Average
26.05%
Excellent
27.44%
Excellent
0.2
Excellent
0.00%
11.1/100
150
₹2132.64
35.5
Average
17.05%
Good
15.42%
Good
0.2
Excellent
0.06%
34.8/100
368
₹1813.06
38.4
Average
9.28%
Poor
11.83%
Average
0.1
Excellent
0.00%
66.6/100
637
₹1297.46
519.0
Average
87.02%
Excellent
82.72%
Excellent
0.0
Excellent
158.76%
Excellent
66.77%
Excellent
0.00%
41.9/100
16
₹1111.34
402.7
Average
1.24%
Poor
2.46%
Poor
0.1
Excellent
61.76%
Excellent
35.83%
Excellent
0.00%
32.3/100
28396
₹1021.99
11.7
Average
9.31%
Poor
9.39%
Poor
0.0
Excellent
10.82%
Good
4.86%
Average
1.50%
62.3/100
42
₹811.32
6.4
Average
12.62%
Average
16.29%
Good
0.0
Excellent
28.35%
Excellent
61.75%
Excellent
0.00%

Hemo Organic Ltd Quarterly Performance

Latest quarterly metrics for HEMORGANIC — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

62.50%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

54.93%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

58.49%

Compounded annual net profit growth over 5 years

Hemo Organic Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for HEMORGANIC — calculated from daily price history

85RSI 14
Overbought — RSI 85

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50
14
▲ Price above SMA 50 — Short-term bullish
SMA 200
13
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
13K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Hemo Organic Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Hemo Organic Ltd (HEMORGANIC) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Hemo Organic Ltd

About HEMORGANIC (Hemo Organic Ltd)

Hemo Organic Ltd is a dynamic trading and distribution company focused on connecting the world's bounty with global markets. We specialize in sourcing and delivering a diverse rang...e of premium agricultural products, ensuring quality and freshness at every stage of the supply chain. From fertile fields to discerning consumers, we facilitate the seamless movement of essential commodities, building reliable partnerships with growers and customers alike. Through meticulous attention to detail and a commitment to ethical practices, Hemo Organic Ltd strives to be a trusted leader in the agricultural trading landscape, contributing to sustainable food security and fostering economic growth in the communities we serve. Our core business revolves around the strategic procurement and distribution of key agricultural staples and specialty produce. We handle significant volumes of grains, including wheat, rice, and maize, playing a vital role in feeding populations worldwide. Beyond grains, we expertly manage the supply chain for a variety of fresh vegetables, such as vibrant capsicums, juicy tomatoes, fiery green chilies, versatile potatoes, crisp cucumbers, and flavorful onions. Furthermore, our expertise extends to the sourcing and distribution of luscious fruits, including crisp apples, exotic red dragon fruit, refreshing sweet limes, and ruby-red pomegranates. By offering a comprehensive portfolio of agricultural products, Hemo Organic Ltd serves as a one-stop solution for businesses seeking reliable supply and consistent quality. Driven by a vision of efficiency and integrity, Hemo Organic Ltd leverages advanced logistics and supply chain management technologies to ensure timely and secure delivery of our products. We maintain a robust network of storage facilities and transportation partners, enabling us to reach customers across India and internationally. Our experienced team is dedicated to providing exceptional customer service, building long-lasting relationships based on trust and mutual success. At Hemo Organic Ltd, we are committed to upholding the highest standards of quality, sustainability, and ethical conduct, ensuring that our operations contribute to a healthier planet and a more prosperous future for all.

Company Details

Symbol:HEMORGANIC
Industry:Trading & Distributors
Sector:Trading & Distributors

Key Leadership

Mr. Vishwambar Kameshwar Singh
Chairman & MD
Mr. Murlidhar Joshi
CFO & Director
Ms. Yukta Prakash Patel
Company Secretary & Compliance Officer

HEMORGANIC Share Price: Frequently Asked Questions

What is the current share price of Hemo Organic Ltd?

Hemo Organic Ltd (HEMORGANIC) trades at ₹21.16 on NSE and BSE. Market cap ₹4.15 (Cr). Educational data only.

What is the P/E ratio of Hemo Organic Ltd?

Hemo Organic Ltd has a P/E of 34.62x vs industry average 35.45x.

What is the Bull Run score for Hemo Organic Ltd?

Hemo Organic Ltd has a Bull Run score of 38.9/100 based on 25+ financial parameters.

Does Hemo Organic Ltd pay dividends?

Hemo Organic Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Hemo Organic Ltd?

Hemo Organic Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Hemo Organic Ltd?

Hemo Organic Ltd has debt-to-equity of N/A.

Is Hemo Organic Ltd a good investment?

Bull Run gives Hemo Organic Ltd a score of 38.9/100. This is not investment advice — consult a SEBI-registered advisor.